2-Guanidinobezimidazole (2GBI) is a NLRP3 agonist with a KD of 1.29 µM and a selective state-dependent HVCN1 blocker. 2-Guanidinobezimidazole directly binds NLRP3s LRR domain, enhances NLRP3-ASC and NLRP3-NEK7 interactions, and drives NLRP3 inflammasome activation. 2-Guanidinobezimidazole can be used for the research of LLC lung carcinoma, B16F10 melanoma and ischemic stroke[1][2].
Molecular Weight:
175.19
Purity:
95.74
CAS Number:
[5418-95-1]
Formula:
C8H9N5
Target:
NOD-like Receptor (NLR),Vasopressin Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted